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Summary
 
Apoptosis of cells must be regulated both positively and negatively in response to a variety of
stimuli in the body. Various environmental stresses are known to initiate apoptosis via differen-
tial signal transduction cascades. However, induction of signals that may inhibit apoptosis is
poorly understood, although a number of intracellular molecules that mediate inhibition of ap-
optosis have been identified. Here we present a novel murine macrophage-specific 54-kD se-
creted protein which inhibits apoptosis (termed AIM, for apoptosis inhibitor expressed by
macrophages). AIM belongs to the macrophage scavenger receptor cysteine-rich domain su-
perfamily (SRCR-SF), members of which share a highly homologous conserved cysteine-rich
domain. In AIM-deficient mice, the thymocyte numbers were diminished to half those in
wild-type mice, and CD4/CD8 double-positive (DP) thymocytes were strikingly more sus-
ceptible to apoptosis induced by both dexamethasone and irradiation
 
 
 
in vivo. Recombinant
AIM protein significantly inhibited cell death of DP thymocytes in response to a variety of
stimuli in vitro. These results indicate that in the thymus, AIM functions in trans to induce re-
sistance to apoptosis within DP cells, and thus supports the viability of DP thymocytes before
thymic selection.
Key words: apoptosis • scavenger receptor cysteine-rich • macrophage • inhibitory factor • 
knockout mouse
 
A
 
poptosis, also called programmed cell death (PCD),
plays a key role in the development and homeostasis
of the body, in a defense mechanism, and in aging (1–4).
Cells die via programmed signal cascades in the developing
embryo during morphogenesis and in adults during cell
turnover, thymic selection of developing thymocytes, or at
the end of an immune response. Thus, apoptosis is in-
volved in diverse physiological situations, and therefore,
disturbed apoptosis may contribute to various diseases, such
as cancer, autoimmunity, infections, or degenerative disor-
ders (5–9).
Accumulating evidence has revealed that many types of
environmental stress initiate apoptosis via differential signal
transduction cascades (10–13). However, apoptosis must be
regulated both positively and negatively in the body; iden-
tification of various intracellular elements, which appear to
behave as negative regulators of apoptosis, strongly indi-
cates the presence of inhibitory mechanisms of apoptosis
that may balance its progression (14–17). Despite the pres-
ence of these intracellular elements, induction of signals
that may inhibit apoptosis is poorly understood, since we
have been ignorant of the extracellular ligands that mediate
inhibitory signals for apoptosis.
In this report, we present a novel murine apoptosis-
inhibitory factor, termed AIM,
 
1
 
 which is secreted exclu-
sively by tissue macrophages. In AIM-deficient (AIM
 
2
 
/
 
2
 
)
mice, the susceptibility of thymocytes to apoptosis induced
 
1
 
Abbreviations used in this paper:
 
 AIM, apoptosis inhibitor expressed by
macrophages; B6, C57Bl/6; BrdU, bromodeoxyuridine; CHO, Chinese
hamster ovary; DN, double negative; DP, double positive; ES, embryonic
stem; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PEC, peri-
toneal exudate cell; RAG, recombination activating gene; SRCR, scav-
enger receptor cysteine-rich; SRCR-SF, scavenger receptor cysteine-rich
domain superfamily; SP, single positive; TdT, terminal deoxynucleotidyl
transferase; TUNEL, TdT-mediated dUTP nick end labeling. 
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by various stimuli was strikingly increased. In vitro, recom-
binant (r)AIM protein significantly inhibited apoptosis of
both thymocytes and a monocyte-derived cell line that ex-
hibits the high binding capacity of AIM.
AIM was originally isolated as a new member of the
scavenger receptor cysteine-rich domain superfamily (SRCR-
SF). SRCR-SF comprises diverse molecules in a broad
range of species, members of which are characterized by
the presence of a unique cysteine-rich domain (SRCR do-
main) initially described in the type I macrophage scaven-
ger receptor (18–20). Although the SRCR domain is
highly conserved among members of the superfamily, each
member appears to have different functions; thus, no con-
sensus role for the SRCR domain has been established.
The identification of AIM will provide clues for investi-
gating the negative regulatory systems of apoptosis via solu-
ble factors. In addition, the apoptosis-inhibitory effect of
AIM may expand the functional concept of the SRCR-SF.
 
Materials and Methods
 
cDNA Library Screening.
 
A mouse macrophage cDNA library
(Clontech) was screened with a fragment of the cysteine-rich do-
main of the mouse scavenger receptor cDNA (positions 1055–
1390, numbered according to reference 20) which was cloned by
PCR. Hybridization of the phage-transferred membrane filters
was performed in 5
 
3
 
 SSC, 0.5% SDS, 5
 
3
 
 Denhardt’s solution at
55
 
8
 
C. Hybridized membrane filters were washed in 2
 
3
 
 SSC,
0.1% SDS at 50
 
8
 
C for 1 h. 47 positive clones were subcloned into
pBluescript SK(
 
1
 
) (Stratagene) and sequenced. Two of them en-
compassed the full-length sequence of the AIM gene.
 
RNA Analysis.
 
Total RNA was isolated from various tissues
of C57Bl/6 (B6) mice and adherent peritoneal exudate cells
(PECs) using RNAzolB solution (Tel-Test Inc.). Adherent PECs
were isolated by the lavage of peritoneal cavities of thioglycol-
late-injected (20 mg i.p.) recombination activating gene (RAG)-
2
 
2
 
/
 
2
 
 mice (21). 10 
 
m
 
g of RNA was denatured, electrophoresed
on a 1% agarose gel, blotted on nylon membrane, and then hy-
bridized with a 
 
32
 
P-labeled AIM cDNA fragment.
 
In Situ Hybridization.
 
Mice were perfused from heart with
4% paraformaldehyde for 30 min. Tissues were removed, then
refixed in the same fixative solution for 24 h. Tissues were dehy-
drated in ethanol, cleared in chloroform, and then embedded in
low-melting-point paraffin (Tissue Prep; Fisher Scientific). Sec-
tions were cut and mounted onto slides coated with 3-aminopro-
pyltriethoxysilane (Aldrich Chemical Co.). Paraffin sections were
subjected to in situ hybridization using digoxigenin-labeled (Boeh-
ringer Mannheim) either hybridizing (antisense) or nonhybrid-
izing (sense) RNA probes transcribed from AIM cDNA sub-
cloned in pBluescript SK(
 
1
 
) plasmid by T3 or T7 RNA
polymerases. Sections were then treated with antidigoxigenin–
alkaline phosphatase, and developed by 4-nitroblue tetrazolium
chloride (NTB). Frozen sections from tissues were stained for
pan-macrophage antigen F4/80 to evaluate AIM-expressing
macrophage subpopulations.
 
Generation of Anti-AIM Abs.
 
Recombinant baculovirus en-
coding AIM protein plus 6xHistidine-Tag was obtained by ho-
mologous recombination with pBlueBac4.5 transfer vector (In-
vitrogen) into which AIM
 
 
 
cDNA fragment encoding the entire
open reading frame was subcloned. The recombinant baculovirus
was infected into 
 
Trichoplusia ni
 
 egg cells (HighFive cells; Invitro-
 
gen), and rAIM protein was purified from the conditioned me-
dium by using a Histidine-Tag affinity column. Rabbits were
immunized four times with purified AIM protein, and IgG sub-
classes including anti-AIM Abs were purified using a protein G
column from rabbit serum. To generate mAbs against AIM,
Balb/c mice were immunized with the rAIM described above in
CFA (Sigma Chemical Co.), and spleen cells were fused with P3-
X63-Ag8-U1 mouse myeloma cells by polyethylene glycol. Su-
pernatants of hybridomas were screened by ELISA using the
rAIM protein as antigen, and three positive clones (5D8, 5H7,
and 3G14) were obtained. The isotype of all Abs was IgG1.
 
Generation of AIM
 
2
 
/
 
2
 
 Mice.
 
A mouse genomic DNA clone
containing exons 2–5 of the AIM gene was isolated by screening
a genomic DNA library derived from the 129/sv mouse strain
(Stratagene). The targeting vector was prepared using a 7-kb
SpeI-BamHI fragment containing exons 2–4 of the AIM gene,
pMC1-neo-polyA (Stratagene) plasmid, and the pBluescript
SK(
 
1
 
) plasmid vector (Stratagene). This construct was designed
to insert the pMC1-neo-polyA gene into the disrupted NcoI site
in exon 3, which encodes the second SRCR domain. The SpeI-
linearized targeting vector was electroporated into E-14.1 embry-
onic stem (ES) cells as described previously (22). G418-resistant
clones were isolated and screened by PCR and Southern blot-
ting. 2 out of 126 G418-resistant clones had undergone the de-
sired homologous recombination. Positive clones were injected
into B6 blastocysts, and chimeric male offspring were mated to
B6 females. Mice carrying the mutation in the heterozygous state
(AIM
 
1
 
/
 
2
 
) were inter-crossed to produce homozygous mutants
(AIM
 
2
 
/
 
2
 
). 4–7-wk-old mice were used for analysis.
 
Serological Reagents and Flow Cytometry.
 
Reagents used for
staining T cells and subsets thereof were as described (22). Thy-
mus, lymph node, and spleen cells were stained with saturating
levels of mAbs and analyzed using a FACSCalibur
 
®
 
 cytometer
(Becton Dickinson).
 
Bromodeoxyuridine Labeling of Thymocytes.
 
Development of DP
cells was assessed by determining bromodeoxyuridine-positive
(BrdU
 
1
 
) DP cells 6 and 12 h after intraperitoneal injection of
2 mg BrdU in PBS. Numbers of BrdU
 
1
 
 DP cells were evaluated
by using a FACSCalibur
 
®
 
 cytometer after staining thymocytes for
CD4, CD8, and BrdU as described previously (23).
 
TUNEL Assay.
 
The terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP nick end labeling (TUNEL) method is
based on the specific binding of TdT to the 3
 
9
 
-OH ends of DNA.
In brief, the periodate-lysine-paraformaldehyde (PLP)-fixed sec-
tions were covered with 2% H
 
2
 
O
 
2
 
 for 5 min at room temperature
to inactivate endogenous peroxidase. After this time period, sec-
tions were rinsed and immersed into TdT buffer (30 mM Tris,
pH 7.2, 140 mM potassium cacodylate, 1 mM calcium chloride)
containing biotinylated dUTP (Bio-11-dUTP) and TdT. Sec-
tions were then nick end–labeled with biotinylated dUTP, intro-
duced by TdT, and stained with avidin-conjugated peroxidase.
Negative controls were stained by omitting TdT from the TdT
buffer to ensure that endogenous peroxidase had been adequately
inactivated.
 
AIM Transfectants and rAIM.
 
AIM cDNA was subcloned into
an expression vector, CAGGS, which contains CMV enhancer,
chicken 
 
b
 
-actin promoter, and rabbit 
 
b
 
-globin exons and intron
(24). The resulting construct (pAc-AIM) was cotransfected with
pMC1-neo-polyA (Stratagene) into Chinese hamster ovary
(CHO) cells by electroporation. Cells were selected by G418,
and 50 resistant clones were obtained. Culture supernatant of
each clone was tested for AIM protein by Western blot analysis
using an anti-AIM Ab. Three clones (#12, 20, and 31) which 
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produced high amounts of AIM protein were used as AIM trans-
fectants. Condition medium from these transfectants, as well as
from nontransfected CHO cells as a control, was used for in vitro
functional analysis of AIM. Approximate concentration of rAIM
in the conditioned medium from transfectants was evaluated by
Western blotting using titrated purified rAIM generated by 
 
T. ni
 
egg cells as controls.
 
In Vitro Thymocyte Apoptosis Induction.
 
Freshly isolated thy-
mocytes (10
 
6
 
/well) were incubated in duplicate with various
concentrations of dexamethasone in the presence of various
amounts of AIM transfectant–conditioned medium. In other ex-
periments, thymocytes were irradiated (
 
137
 
Cs) and then incubated
in the presence of various amounts of AIM transfectant–condi-
tioned medium. To normalize any nonspecific effect potentially
caused by conditioned medium, the amount of conditioned me-
dium was equalized by adding conditioned medium from non-
transfected CHO cells into wells that contained low or no
amounts of conditioned medium from AIM transfectants. 20 h
later, numbers of surviving DP cells were calculated by trypan
blue exclusion and CD4/CD8 staining.
 
Binding Study.
 
rAIM protein and a control protein (a tran-
scription factor localized in the nucleus) were generated by re-
combinant baculovirus–infected 
 
T. ni
 
 egg cells as described
above. These proteins were biotinylated using the Immunoprobe
Biotinylation kit (Sigma Chemical Co.) and resuspended in PBS
at 1 mg/ml. 5 
 
3 
 
10
 
5
 
 J774A.1 cells were incubated with biotiny-
lated rAIM or biotinylated control protein at 10 
 
m
 
g/ml in PBS
containing 5% FCS for 1 h on ice. Cells were washed twice and
then incubated with streptavidin-FITC (PharMingen) for 20 min
on ice. After two washes, cells were analyzed using a FACScan
 
®
 
cytometer (Becton Dickinson).
 
CD95/Fas-mediated Apoptosis.
 
To induce apoptosis in J774A.1
cells, cells (10
 
4
 
/well) were incubated with 0.1
 
 m
 
g/ml of cyclohex-
imide (provided by Dr. P. Vito, Basel Institute) and various concen-
trations of hamster anti–mouse CD95/Fas mAb (clone Jo2; Phar-
Mingen [25]) plus rabbit mAbs cocktail anti–hamster IgG (clones
G70-204 and G94-56; PharMingen), in the presence or absence
of rAIM at 
 
z
 
1 ng/ml (final) for 20 h. Cell viability was measured
by [
 
3
 
H]thymidine incorporation in the last 4 h as described (25).
 
Results
 
Identification of a Novel Murine SRCR-SF Member Mole-
cule, AIM.
 
During a search for new SRCR-SF members
by low-stringent screening of various cDNA libraries using
the cysteine-rich domain sequence of the mouse scavenger
receptor as a probe, we have isolated the cDNA for a novel
murine SRCR-SF molecule, termed AIM, from a mouse
macrophage cDNA library (Fig. 1 a). AIM has features of a
secreted protein characterized by a potential signal-peptide
sequence, and no transmembrane-like hydrophobic region
(Fig. 1 a). AIM contains three SRCR domains, each of
which is well conserved in other SRCR-SF members (Fig.
1 a).
Native AIM protein was immunoprecipitated from mac-
rophage cell lysates, using anti-AIM polyclonal Abs which
were generated by immunizing animals with an rAIM
protein (Fig. 1 b). After SDS-PAGE, a protein of 
 
z
 
54 kD
was apparent, consistent with the predicted size including
N-linked glycans.
 
Expression Distribution of AIM Gene.
 
The tissue distri-
bution of AIM gene expression was determined by North-
ern blot analysis. As shown in Fig. 2 a, a unique AIM
mRNA of 
 
z
 
1.9 kb was expressed strongly in adherent
PECs, which are mostly macrophages, and weakly in
spleen and liver. The lack of a longer form suggests that no
transmembrane form exists. AIM gene expression was also
detected in the thymus by reverse transcription PCR (data
not shown). To further characterize its expression distribu-
tion in tissues, in situ mRNA hybridization was performed
on thymus, spleen, and liver tissues as well as bacillus Cal-
mette Guérin (BCG)-induced granulomas in the liver,
which harbor large numbers of infiltrating macrophages
(26, 27). Interestingly, as shown in Fig. 2, b and c, mac-
rophages at the peripheral area of granulomas, which are
susceptible to environmental inflammatory stresses, express
AIM. In contrast, macrophages at the central area of granu-
lomas showed almost no AIM expression. A subpopulation
of thymic macrophages in the cortex expressed AIM
mRNA (Fig. 2, d and e). However, AIM expression was
not detected in medullary macrophages after evaluation of
numerous sections. In the spleen, AIM mRNA was ex-
pressed predominantly by macrophages in the marginal
zone at the interface of the white and red pulps (Fig. 2, f
and g). In the liver, strong signals were observed in a subset
of, but not all, Kupffer/macrophage cells (Fig. 2, h and i).
Thus, AIM gene appears to be expressed exclusively in tis-
sue macrophages. However, in each tissue only a subpopu-
Figure 1. (a) Amino acid sequence of mouse (Balb/c strain) AIM.
Dash-underlined sequence corresponds to the potential leader sequence.
N-glycosylation sites (three sites) are shaded. Three SRCR domains are
indicated by boxes and denoted by SRCR-1, -2, and -3. ., exon–intron
junctions. The aspartic acid at position 197 (circled) is serine in the 129/sv
strain, based on the nucleotide substitution of adenine in the Balb/c strain
to guanine in the 129/sv mouse strain. The cDNA sequence of AIM is
available from EMBL/GenBank/DDBJ under accession no. AF011428.
(b) Peritoneal macrophages were lysed in 0.5% Triton-X buffer, and AIM
protein was immunoprecipitated. Immunoprecipitating Ab was anti-AIM
polyclonal rabbit Ab, which was generated by immunizing rAIM into the
animal. Precipitated protein (right) as well as conditioned medium (5 ml)
from either AIM-transfected CHO cells (left) or nontransfected CHO
cells (middle) were size-fractionated on 10% SDS-PAGE, blotted on a
membrane, and stained by anti-AIM mAb (clone 3G14). Signals were de-
veloped by the ECL system (Amersham Pharmacia Biotech). 
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Figure 2. (a) Tissue distribution of AIM
gene expression. 10 mg of total RNA from
various mouse (B6) tissues and from adher-
ent PECs induced by thioglycollate from
RAG-22/2 mouse was hybridized with
either AIM cDNA or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA
fragment. Weak background signals de-
rived from 18S rRNA, which is slightly
shorter than AIM rRNA, can be detected in
every tissue. In this experiment, adherent
PECs were prepared from RAG-22/2 mice
to avoid any contamination of T and B (B-1
and B-2) cells. However, almost compara-
ble expression was detected in the adherent
PECs from wild-type B6 mice (data not
shown). (b–i) In situ hybridization analysis
of AIM expression (violet/dark blue signals
in b, d, f, and h) and its comparison with
immunolocalization of pan-macrophage
antigen, F4/80 (dark brown signals in c, e,
g, and i), in mouse granulomas in the liver
(b and c), thymus (d and e), spleen (f and g),
and liver (h and i). (b and c) AIM is ex-
pressed in a subset of macrophages in the
peripheral areas of granulomas (gp) but not
in the central areas (gc). g, granulomas; lv,
liver tissue. (d and e) AIM is expressed by a
subpopulation of cortical macrophages as
indicated by arrows (d), although macro-
phages exist in both cortex and medulla (e).
c, cortex; m, medulla. (f and g) AIM is ex-
pressed predominantly by a subset of mac-
rophages in the marginal zones. r, red pulp;
w, white pulp; mz, marginal zone. (h and i)
AIM is expressed by a subpopulation of
Kupffer/macrophage cells. Original magni-
fications: b, 3400; c, e, g, h, and i, 3100; d
and f, 3200. (j) No AIM expression was
detected in cultured macrophages. Adherent
PECs were prepared from intraperitoneal
thioglycollate-injected RAG-22/2 mice. A
portion of the cells were cultured on plastic
dishes for 16 h in complete DMEM con-
taining 10% FCS. Total RNA was prepared
from freshly isolated and cultured macro-
phages, and hybridized with either AIM or
GAPDH cDNA fragment. 
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lation of macrophages express AIM. This observation may
reflect a requirement for specific microenvironments for
AIM gene expression. This is consistent with the lack of
AIM mRNA in lung, which is rich in macrophages (see
Fig. 2 a). According to the AIM expression pattern in gran-
ulomas (Fig. 2, b and c), inflammatory stimuli might upreg-
ulate AIM expression in macrophages. Alternatively, cell–
cell interaction between macrophages and specific types of
cells in tissues might be necessary for AIM gene expression.
Supporting this, freshly isolated peritoneal macrophages
(which were induced by thioglycollate) expressed AIM
mRNA strongly, but AIM expression disappeared com-
pletely once these cells were cultured on plastic dishes for
16 h (Fig. 2 j), and could not be reinduced by PMA, LPS,
or several cytokines, including IFN-
 
g
 
 and interleukins
(data not shown).
AIM resembles a recently reported human SRCR-SF
member, Sp
 
a
 
, the function of which is still unknown (28),
raising the possibility that AIM could be the mouse homo-
logue of Sp
 
a
 
. However, since tissue distribution patterns of
AIM and Sp
 
a
 
 do not appear very similar (28), relationship
between AIM and Sp
 
a
 
 remains to be established.
 
Reduced Numbers of CD4/CD8 DP Thymocytes in AIM
 
2
 
/
 
2
 
Mice.
 
To gain insight into the physiological function of
AIM, we produced a mouse line incapable of making AIM
protein by mutating the AIM gene locus. Null mutation of
the AIM gene was generated by inserting a neomycin resis-
tance gene into exon 3, which encodes the SRCR-2
domain, via homologous recombination in ES cells (Fig.
3 a). The resulting AIM-null (AIM
 
2
 
/
 
2
 
) mice were born at
the expected Mendelian frequency and were apparently
healthy under specific pathogen–free conditions.
However, thymi from AIM
 
2
 
/
 
2
 
 mice harbored signifi-
cantly fewer thymocytes compared with AIM
 
1
 
/
 
1
 
 littermate
mice (0.68 
 
6 
 
0.2 
 
3 
 
10
 
8
 
 in AIM
 
2
 
/
 
2
 
 vs. 1.32 
 
6 
 
0.3 
 
3 
 
10
 
8
 
 in
AIM
 
1
 
/
 
1
 
 
 
mice; 
 
n
 
 
 
5
 
 14 each). Among the subpopulations of
thymocytes dissected by CD4/CD8 surface expression, the
CD4/CD8 DP thymocyte numbers in AIM
 
2
 
/
 
2
 
 mice were
diminished to less than half the number in AIM
 
1
 
/
 
1
 
 mice,
whereas the numbers of either CD4/CD8 DN immature
thymocytes or mature single-positive (SP) thymocytes
were grossly comparable in mutant and wild-type animals
(Table I). Related to this, in the CD3 expression histogram
of total thymocytes, the relative percentage of high CD3–
expressing cells, which correspond to the mature SP thymo-
cytes, was increased by twofold in AIM
 
2
 
/
 
2
 
 mice compared
with AIM
 
1
 
/
 
1
 
 mice (Fig. 3 b). Thus, there is an exclusive de-
crease in DP thymocyte numbers in AIM
 
2
 
/
 
2 mice.
Normal Thymocyte Development from the DN to the DP
Stage in AIM2/2 Mice. To assess whether the DP cell–
NcoI-XbaI hybridizable fragments in wild-type and mutant DNA, re-
spectively. (b) Thymocyte suspensions from AIM2/2 (2/2) and AIM1/1
(1/1) mice were stained for CD3 and then analyzed by flow cytometry.
Histograms of CD3 expression of total thymocytes are displayed. Relative
percentage of CD3high population (which corresponds to mature SP thy-
mocytes) in each type of mice is represented. (c) Apoptosis was induced
in vivo in AIM1/1 (1/1, white boxes) and AIM2/2 (2/2, black boxes)
mice by (c) injection of 0.1 or 0.2 mg i.p. of dexamethasone in PBS, or
PBS alone, or (d) 0, 2, or 4 Gy of irradiation (137Cs). 48 h after stimula-
tion, mice were killed and the number of surviving DP thymocytes was
determined by trypan blue exclusion and CD4/CD8 staining. Values rep-
resent the average viability of DP cells from two or three mice of each
genotype and are normalized to the percentage of viable cells remaining
in nonstimulated (PBS-injected, or nonirradiated) mice. Bars, SD. Three
sets of experiments were performed for each stimulation, and similar re-
sults were obtained.
Figure 3. (a) Knockout strategy. Restriction maps are shown for the
wild-type AIM gene locus (top), targeting vector (middle), and recombi-
nant (bottom) gene locus. Exons, white boxes. neor, neomycin resistance
gene (black box). pBluescript vector sequence, dashed line. Restriction
sites: B, BamHI; N, NcoI; S, SpeI; Xb, XbaI; Xh, XhoI. Probe DNA
fragment for Southern blotting is indicated, as are the 2.1- and 3.5-kb418 AIM, a Novel Apoptosis Inhibitory Factor
specific decrease in AIM2/2 mice might be due to impaired
kinetics of thymocyte development from the CD4/CD8
DN stage to the DP stage, we evaluated the kinetics of thy-
mocyte maturation by biosynthetic labeling of thymocytes
using BrdU in AIM1/1 and AIM2/2 mice. DN cells ex-
hibit a high degree of cell cycling, resulting in massive pro-
liferation of cells during development to the DP stage,
whereas DP cells no longer proliferate (29). Hence, in
vivo–injected BrdU is incorporated by DN cells but not by
DP cells. Therefore, we evaluated BrdU1 subpopulations
in DP cells 6 and 12 h after BrdU pulse-injection into mice
to determine the generation of DP cells in these time peri-
ods. However, comparable numbers of BrdU1 DP cells
were observed at each time point in AIM1/1 and AIM2/2
mice (4.8 3 106 in AIM1/1 vs. 4.5 3 106 in AIM2/2 after
6 h, 8.8 3 106 in AIM1/1 vs. 9.0 3 106 in AIM2/2 mice
after 12 h; n 5 2 each). This result indicates no develop-
mental defect of thymocytes from the DN to the DP stage
in AIM2/2 mice.
Increased Susceptibility of DP Thymocytes to Apoptosis in
AIM2/2 Mice. An alternative explanation for the decrease
of DP thymocytes is that DP cells in AIM2/2 mice might
be more sensitive to apoptosis, resulting in increased sus-
ceptibility to death in response to environmental stimuli. In
many mice with mutant apoptosis-related genes, alteration of
susceptibility to apoptosis is often most apparent in the thy-
mus (30–36), since thymocytes are highly sensitive to apop-
tosis (37–39). To assess the susceptibility of DP thymocytes
to apoptosis in AIM2/2 mice, both mutant and wild-type
mice were challenged in vivo with either various amounts
of dexamethasone or irradiation, both of which induce
massive apoptosis in thymocytes via different pathways. As
shown in Fig. 3, c and d, AIM2/2 mice harbored far fewer
numbers of surviving DP thymocytes after either stimula-
tion than AIM1/1 mice, indicating a strikingly increased
susceptibility of DP cells to cell death in response to both
dexamethasone and irradiation in AIM2/2 mice. We con-
firmed that enhanced death of DP thymocytes in AIM2/2
mice after dexamethasone or irradiation treatment was due
to massive apoptosis in the cortex, by the TdT-based
TUNEL method (data not shown). Taken together, these
results strongly indicate that AIM acts as an apoptosis-
inhibitory factor in the thymus. Before positive selection,
which promotes development of DP cells to the SP cell
stage, DP cells lack Bcl-2 expression (40–42) and are thus
highly susceptible to apoptosis triggered by diverse envi-
ronmental factors. By increasing resistance to death, AIM
may augment the viability of DP cells undergoing positive
selection. Perhaps related to this, the proportions of periph-
eral lymph node T cells expressing several TCR variable
chains were different in AIM1/1 and AIM2/2 mice at sta-
tistically significant levels: 0.6 6 0.2% in AIM2/2 vs. 1.8 6
0.4% in AIM1/1 (P , 0.05) in Va3.21 CD4 cells; and 7.0 6
0.2% in AIM2/2 vs. 9.2 6 0.4% in AIM1/1 (P , 0.01) in
Vb61 CD4 cells (n  5 5 each of AIM2/2 and AIM1/1
mice). In AIM2/2 mice, a proportion of thymocytes might
fall into cell death before they are positively selected, re-
sulting in a skew of V-chain repertoire.
Mature SP cells exhibited similar susceptibility to apop-
tosis induced by either dexamethasone or irradiation in
AIM1/1 and AIM2/2 mice (data not shown). This is com-
patible with the grossly comparable numbers of SP cells in
nonstimulated AIM1/1 and AIM2/2 mice (see Table I).
During maturation from the DP stage to the SP stage, there
is a large increase in Bcl-2 expression levels (40–42).
Therefore, cell death of SP thymocytes may be predomi-
nantly inhibited by Bcl-2. When assessed by Western blot-
ting, Bcl-2 expression levels in SP cells were similar in
AIM1/1 and AIM2/2 mice (data not shown).
Thymocytes Express Normal Levels of Various Apoptosis-
inhibiting and -initiating Elements in AIM2/2 Mice. A num-
ber of intracellular molecules have been implicated as in-
hibitory mediators of apoptosis. Of these, a stress-signaling
kinase Sek-1 (c-Jun NH2-terminal kinase kinase [JNKK]/
mitogen-activated protein kinase kinase 4 [MKK4]) and a
Bcl-2–related protein Bcl-x are expressed in DP thy-
mocytes. Lack of either molecule in vivo caused increased
susceptibility of DP cells to apoptosis in mutant mice of
these genes (16, 35, 36). To assess whether the AIM-medi-
ated inhibitory signal is related to the expression levels of
these molecules, we determined protein levels of Sek-1 and
Bcl-x in thymocytes from AIM1/1 and AIM2/2 mice.
However, no difference was observed in mutant and wild-
type mice as evaluated by Western blotting (data not
shown). Since most DP thymocytes do not express Bcl-2
(40–42), possible involvement of Bcl-2 in the AIM-medi-
ated apoptosis inhibition within DP cells can be excluded.
In addition, we evaluated the expression levels of CD95/
Fas (also called APO-1), TCR, and glucocorticoid recep-
tor, all of which trigger the initiation of apoptosis in DP
thymocytes. Again, no difference was observed in thy-
mocytes from AIM1/1 and AIM2/2 mice as assessed by
Western blotting and fluorocytometric analysis (data not
shown).
AIM Directly Inhibits Apoptosis of DP Thymocytes. We next
determined whether AIM acts directly on thymocytes as an
apoptosis-inhibitory factor. We evaluated the inhibition of
apoptosis of DP thymocytes by AIM in vitro by using puri-
fied thymocytes from AIM2/2 mice and rAIM protein
generated by AIM-transfected CHO carcinoma cells. As
demonstrated in Fig. 4, viability of cells after treatment
Table I. Absolute Numbers of Thymocyte Subpopulations
1/12 /2
Total 1.32 6 0.3 3 108 0.68 6 0.2 3 108
DP 1.1 6 0.2 3 108 0.44 6 0.15 3 108
CD41 SP 1.53 6 0.2 3 107 1.32 6 0.2 3 107
CD81 SP 6.2 6 0.3 3 106 6.1 6 0.4 3 106
DN 4.8 6 0.4 3 106 4.8 6 0.6 3 106
Cell numbers of each thymocyte subpopulation from AIM1/1 and
AIM2/2 mice (n 5 14 each) are presented.419 Miyazaki et al.
with either dexamethasone (Fig. 4 a) or irradiation (Fig. 4
b) was improved in the presence of rAIM in a dose-depen-
dent fashion, suggesting that the inhibition of apoptosis of
DP thymocytes by AIM appears to be a direct effect. AIM
did not stimulate the thymocyte proliferation that may re-
sult in a seemingly improved cell survival, as assessed by
[3H]thymidine incorporation by thymocytes in the pres-
ence or absence of rAIM (data not shown).
AIM Also Inhibits CD95/Fas-mediated Apoptosis of a
Monocyte-derived Cell Line. AIM appears to bind to the
surface of various cell types including several cell lines, as
assessed by binding studies using rAIM (Hirokami, Y., and
T. Miyazaki, manuscript in preparation). Of these cells, a
monocyte-derived cell line, J774A.1, showed strong bind-
ing capacity for AIM (Fig. 5 a). Therefore, by using this
cell line we assessed whether the apoptosis-inhibitory effect
of AIM is restricted to thymocytes or may be more general.
Since J774A.1 cells express high cell surface levels of
CD95/Fas antigen (Fig. 5 b), we induced apoptosis within
J774A.1 cells by CD95/Fas cross-linking in combination
with cycloheximide (43) in the presence or absence of
rAIM in vitro, and determined their viability. As demon-
strated in Fig. 5 c, the presence of rAIM again improved
cell viability after treatment with different concentrations
of anti-CD95/Fas Ab. This result strongly suggests that
AIM may inhibit apoptosis not only of thymocytes but also
Figure 4. (a) Freshly isolated thymocytes (106/well) from AIM2/2
mice (adherent cells, including macrophages, were depleted by cell incu-
bation on culture plates for 30 min) were incubated with 5 or 10 nM
dexamethasone in the presence of conditioned medium of AIM transfec-
tants at indicated concentrations of rAIM (final) for 20 h. To normalize
any nonspecific effect potentially caused by conditioned medium, the
amount of conditioned medium was equalized by adding conditioned
medium from nontransfected CHO cells into wells which contained low
or no amounts of conditioned medium of AIM transfectants. (b) Thy-
mocytes were 50 or 100 cGy irradiated and then incubated in the pres-
ence of various concentrations of rAIM as above. Surviving DP cells were
calculated by trypan blue exclusion and CD4/CD8 staining. Values rep-
resent the average viability of DP cells from two independent wells and
are normalized to the percentage of the DP cell numbers before culture.
Bars, SD. Two sets of experiments were performed for each stimulation,
and similar results were obtained.
Figure 5. (a) AIM binding capacity of J774A.1 cells is presented as log
fluorescence by black histograms, and the control protein bindings that
are regarded as backgrounds are represented by white histograms. (b)
CD95/Fas expression on the surface of J774A.1 cells. Cells were incu-
bated with 50 mg/ml of mouse IgG for 15 min on ice to block nonspe-
cific binding of Abs via Fc receptors. Cells were washed once, stained
with FITC-conjugated anti-CD95/Fas (clone Jo2), and then analyzed by
flow cytometry. White histogram, unstained cells as a control. (c) J774A.1
cells (104/well) were cultured with various concentrations of hamster
anti-CD95/Fas mAb plus rabbit mAbs cocktail anti–hamster IgG and 0.1
mg/ml of cycloheximide, in the presence (z1 ng/ml; white boxes, 1) or
absence (black boxes, 2) of rAIM. After 16 h of culture, [3H]thymidine
(1 mCi/well) was pulsed, and cells were further incubated for 4 h and
then harvested. Values represent the average [3H]thymidine incorporation
from three independent wells and are normalized to the percentage of the
incorporation observed without Abs. Bars, SD. Three sets of experiments
were performed for each stimulation, and similar results were obtained.
(d) J774A.1 cells (104/well) were cultured for 16 h in the presence or ab-
sence of rAIM, but without anti-CD95 mAb and cycloheximide. Cells
were pulsed with [3H]thymidine (1 mCi/well), further incubated for 4 h,
and then harvested. Values represent the average [3H]thymidine incorpo-
ration from three independent wells. Bars, SD.420 AIM, a Novel Apoptosis Inhibitory Factor
of a spectrum of target cells to which AIM binds. In addi-
tion, inhibition of CD95/Fas-mediated death by AIM, to-
gether with inhibition of either dexamethasone- or irradia-
tion-induced thymocyte apoptosis, demonstrates that AIM
induces resistance to multiple initiations of apoptosis.
Treatment of J774A.1 with rAIM in culture did not alter
the cell surface CD95/Fas expression levels (data not
shown), excluding rescue of cells by AIM from apoptosis
by downregulation of CD95/Fas expression. In addition,
rAIM did not modulate the proliferation of J774A.1 cells as
assessed by [3H]thymidine incorporation in the absence of
anti-CD95 mAb (and cycloheximide; Fig. 5 d), indicating
that the improved cell viability observed in the presence of
rAIM was certainly due to the inhibition of death as in the
case of thymocytes.
Discussion
AIM, a Novel Apoptosis Inhibitory Factor. In this report,
we described a novel murine secreted protein that inhibits
apoptosis; AIM appears to increase resistance to multiple
initiations of apoptosis. AIM was originally identified as a
new member of the SRCR-SF. However, no other
SRCR-SF member is known to be involved in the inhibi-
tion of apoptosis, reflecting the diverse functions of
SRCR-SF member molecules.
The inhibition of apoptosis of purified DP thymocytes
by rAIM in vitro clearly demonstrated that AIM directly
functions on DP thymocytes. These in vitro experiments
using purified thymocytes and rAIM exclude the possibili-
ties that (a) AIM might be a counter-ligand for receptors
that promote apoptosis, and thus might work as an antago-
nist of other apoptosis-regulating factors in the thymus; and
(b) AIM might alter the recognition threshold at which
macrophages engulf cells undergoing apoptosis and, as a
consequence, AIM2/2 mice might have fewer surviving
cells after stimuli that induce apoptosis.
However, the molecular mechanism of the inhibitory ef-
fect mediated by AIM remains to be established. According
to the comparable levels of apoptosis-initiating molecules
(CD95/Fas, TCR, glucocorticoid receptor) and intracellu-
lar apoptosis-inhibiting elements (Bcl-x, Bcl-2, Sek-1) in
thymocytes of AIM2/2 and AIM1/1 mice, AIM appears to
inhibit apoptosis of cells not simply by modulating the ex-
pression of these known apoptosis-related molecules, but
by mediating an independent signaling cascade.
Two Independent Modes of Thymocyte Protection from Apop-
tosis. AIM-mediated inhibition of apoptosis within DP
thymocytes revealed two major physiological modes for
protecting thymocytes from death in the thymus. In the
cortex, AIM is secreted by a subset of macrophages, and
functions in trans to decrease DP thymocyte susceptibility
to apoptosis, thus protecting DP cells from death until they
are positively selected. In contrast, in the medulla, Bcl-2
expression is upregulated in SP cells after positive selection,
and induces strong resistance to apoptosis within SP cells
themselves (40–42). This model appears to be consistent
with the observations by Kyewski and colleagues demon-
strating that a subset of cortical macrophages form “ro-
settes” with DP cells in the thymus (44, 45), and that the
DP thymocytes associated with these macrophages are se-
lectively protected from either spontaneous or experimen-
tally induced apoptosis both in vivo and in vitro (46; and
Kyewski, B.A., unpublished observations). It may be possible
that in the thymus, subsets of cortical macrophages have the
advantage of associating with DP thymocytes, perhaps via
chemoattractants or ligation of surface molecules, and thus
support the viability of associated DP cells via AIM. The
skewing of several TCR V-chain repertoires in AIM2/2
mice might reflect unscheduled death of a proportion of
thymocytes undergoing positive selection caused by the
lack of AIM, which may augment their viability before se-
lection. However, further studies are required to investi-
gate more precisely the influence of AIM on T cell reper-
toire formation. Interestingly, macrophages also induce
death within DP thymocytes via MHC–TCR interactions
or by secreting various effectors (47). Hence, macrophages
might balance the progression of apoptosis of DP thy-
mocytes by differentially mediating either positive or nega-
tive signals depending on microenvironmental stimuli.
AIM Functions on a Variety of Cell Types. Inhibition of
apoptosis of J774A.1 cells by AIM in vitro suggests that the
apoptosis-inhibitory effect of AIM is more general; AIM
could be involved in the negative regulation of apoptosis,
not only of DP thymocytes but also of other types of cells
in the body to which AIM binds, in the specific microenvi-
ronments where AIM expression is induced in macro-
phages. For instance, AIM might play important roles at in-
flammatory and infectious sites, according to the following
observations by in situ analysis: (a) AIM expression appears
to be increased in activated macrophages at inflammatory
sites; and (b) in the spleen, AIM is predominantly expressed
by macrophages in the marginal zone, which are highly
susceptible to blood-borne pathogen exposure. It is estab-
lished that apoptosis of both effector hematopoietic cells
and target cells is involved in the progression of inflamma-
tion and infectious disease (3, 4). Therefore, AIM might
balance the apoptosis of these cells by its inhibitory effect,
thus regulating progression of the disease. Further charac-
terization of AIM particularly by using AIM2/2 mice will
clarify the in vivo roles in some pathological situations of
the negative regulation of apoptosis directed by macro-
phages.
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